Clearwater has advised VIO Chemicals, a Zurich-based company with leading chemical R&D expertise on its sale to Biosynth, a supplier of critical raw materials to the life science industry.
VIO Chemicals is specialised in the custom design and production of specialty chemicals, intermediates and Active Pharmaceutical Ingredients (APIs). The story of VIO Chemicals began with a passion for chemistry as a start-up company in the high-end business environment of Zurich, Switzerland in 2001. It has since grown to a global provider with a portfolio of 2,500 products delivered to the world's leading companies all over the Americas, over 20 European countries and Asia. Today, VIO Chemicals is the exclusive and trusted partner for customers and suppliers in the chemical and pharmaceutical industry worldwide.
Biosynth is a supplier of critical materials, securing life science supply chains with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, Biosynth’s expertise and capability runs across Complex Chemicals, Peptides, and Key Biologics, all from one trusted partner. Headquartered in Staad, Switzerland, Biosynth is owned amongst others by KKR, Ampersand Capital Partners and management.
